NCT02953275View on ClinicalTrials.gov

Synergistic Effect of Vedolizumab and Pentoxifylline

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

April 13, 2017

Primary Completion Date

March 18, 2019

Study Completion Date

June 13, 2019

Conditions

Crohn Disease

Interventions

DRUG

vedolizumab

standard of care

DRUG

Pentoxifylline

added to vedolizumab

DRUG

placebo

added to vedolizumab

Trial Locations (1)

33136

University of Miami Crohn's and Colitis Center, Miami

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Takeda

INDUSTRY

lead

University of Miami

OTHER